Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bristol Rx Expansion Plans Include Biologics Manufacturing

Executive Summary

Bristol plans to expand into biologics development and manufacturing as part of its "external development" plans for the pharmaceutical division following the divestments of Clairol and Zimmer.

You may also be interested in...



Roche Tries Genentech Formula In Japan: Chugai Deal Follows 1990 Model

Roche will have "opt-in" rights on Chugai's Phase II rheumatoid arthritis agent in the U.S. as part of the merger agreement between the two firms

Roche Tries Genentech Formula In Japan: Chugai Deal Follows 1990 Model

Roche will have "opt-in" rights on Chugai's Phase II rheumatoid arthritis agent in the U.S. as part of the merger agreement between the two firms

Bristol BuSpar Share Halved By Generics; DuPont Deal Shows "Flexibility"

Bristol-Myers Squibb's BuSpar (buspirone) market share has been cut by more than half since the launch of generic products at the end of March.

Related Content

UsernamePublicRestriction

Register

PS036677

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel